Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Sell
1,144
-132
-10% -$45.2K 0.17% 90
2026
Q1
$449K Hold
1,276
0.2% 86
2025
Q4
$418K Buy
+1,276
New +$405K 0.18% 88
2025
Q2
$369K Hold
1,251
0.17% 98
2025
Q1
$390K Sell
1,251
-64
-5% -$18.9K 0.19% 89
2024
Q4
$343K Hold
1,315
0.17% 99
2024
Q3
$424K Sell
1,315
-204
-13% -$66.7K 0.21% 91
2024
Q2
$475K Hold
1,519
0.25% 80
2024
Q1
$432K Sell
1,519
-121
-7% -$35.4K 0.23% 88
2023
Q4
$472K Sell
1,640
-25
-2% -$6.81K 0.27% 79
2023
Q3
$447K Hold
1,665
0.28% 82
2023
Q2
$390K Buy
+1,665
New +$386K 0.23% 91

Other funds holding AMGN

Union Savings Bank's AMGN Position: Q2 2026 in Review

Union Savings Bank reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $45.2K and leaving 1,144 shares worth $414K. The position accounts for 0.17% of the portfolio, ranked #90.

Union Savings Bank first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $475K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Union Savings Bank held 1,144 shares of Amgen worth $414K as of Q2 2026.
  • Union Savings Bank sold 132 Amgen shares in Q2 2026, an estimated $45.2K.
  • Amgen made up 0.17% of Union Savings Bank's portfolio in Q2 2026, its #90 holding.
  • Union Savings Bank first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's Amgen position peaked at $475K in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.